Literature DB >> 10103316

Pitfall in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis.

J F Chmiel1, M L Drumm, M W Konstan, T W Ferkol, C M Kercsmar.   

Abstract

In this report, we present an asymptomatic infant, seen for a second opinion, who was given the diagnosis of cystic fibrosis (CF) as a neonate based on the presence of two mutant alleles, DeltaF508 and R117H. The diagnosis of CF adversely affected the family's emotional, employment, and financial statuses. Our evaluation included sweat chloride, nasal transepithelial potential difference, and bronchoscopy with bronchoalveolar lavage measurements, all which were consistent with findings expected from an individual without CF. Genotype analysis for the sequence polymorphism in intron 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene revealed the 7 thymidines and 9 thymidines alleles. We conclude that this patient probably expresses enough epithelial cell surface CFTR function such that she has a normal phenotype. Based on our evaluation, she does not meet the current diagnostic criteria for CF. Although genotype analysis can be an useful adjunct, it should not be the sole diagnostic criterion for CF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10103316     DOI: 10.1542/peds.103.4.823

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2005-11

Review 2.  Newborn screening for cystic fibrosis.

Authors:  Jack K Sharp; Michael J Rock
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

3.  Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Authors:  Philip M Farrell; Beryl J Rosenstein; Terry B White; Frank J Accurso; Carlo Castellani; Garry R Cutting; Peter R Durie; Vicky A Legrys; John Massie; Richard B Parad; Michael J Rock; Preston W Campbell
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

Review 4.  Genome sequencing and implications for rare disorders.

Authors:  Jennifer E Posey
Journal:  Orphanet J Rare Dis       Date:  2019-06-24       Impact factor: 4.123

Review 5.  Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders.

Authors:  Samuel M Moskowitz; James F Chmiel; Darci L Sternen; Edith Cheng; Ronald L Gibson; Susan G Marshall; Garry R Cutting
Journal:  Genet Med       Date:  2008-12       Impact factor: 8.822

6.  Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis.

Authors:  Vinícius Buaes Dal'Maso; Lucas Mallmann; Marina Siebert; Laura Simon; Maria Luiza Saraiva-Pereira; Paulo de Tarso Roth Dalcin
Journal:  J Bras Pneumol       Date:  2013 Mar-Apr       Impact factor: 2.624

7.  Development of allele-specific multiplex PCR to determine the length of poly-T in intron 8 of CFTR.

Authors:  Neng Chen; Anne E Prada
Journal:  PeerJ       Date:  2014-07-08       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.